We increase our TP for MSN by 2% on news that private equity firm KKR will acquire 7.5% of Masan Nutri-Science (MNS) via the purchase of primary shares worth USD150 million. However, we lower our rating from BUY to OUTPERFORM as MSN has rallied 13.5% sinc